Parametric Portfolio Associates’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-193,848
| Closed | -$659K | – | 4026 |
|
|
2018
Q3 | $659K | Sell |
193,848
-168,661
| -47% | -$573K | ﹤0.01% | 3304 |
|
|
2018
Q2 | $1.36M | Buy |
362,509
+89,528
| +33% | +$337K | ﹤0.01% | 2897 |
|
|
2018
Q1 | $1.12M | Sell |
272,981
-52,405
| -16% | -$214K | ﹤0.01% | 2960 |
|
|
2017
Q4 | $1.51M | Buy |
325,386
+133,536
| +70% | +$621K | ﹤0.01% | 2787 |
|
|
2017
Q3 | $1.36M | Sell |
191,850
-2,288
| -1% | -$16.2K | ﹤0.01% | 2843 |
|
|
2017
Q2 | $1.4M | Buy |
194,138
+1,156
| +0.6% | +$8.36K | ﹤0.01% | 2783 |
|
|
2017
Q1 | $1.19M | Buy |
192,982
+72,436
| +60% | +$446K | ﹤0.01% | 2774 |
|
|
2016
Q4 | $706K | Buy |
120,546
+96,842
| +409% | +$567K | ﹤0.01% | 3016 |
|
|
2016
Q3 | $126K | Sell |
23,704
-2,247
| -9% | -$11.9K | ﹤0.01% | 3647 |
|
|
2016
Q2 | $172K | Buy |
25,951
+1,328
| +5% | +$8.8K | ﹤0.01% | 3643 |
|
|
2016
Q1 | $115K | Sell |
24,623
-1,533
| -6% | -$7.16K | ﹤0.01% | 3845 |
|
|
2015
Q4 | $132K | Buy |
26,156
+5,210
| +25% | +$26.3K | ﹤0.01% | 3821 |
|
|
2015
Q3 | $74K | Sell |
20,946
-28,616
| -58% | -$101K | ﹤0.01% | 3214 |
|
|
2015
Q2 | $495K | Sell |
49,562
-15,776
| -24% | -$158K | ﹤0.01% | 3286 |
|
|
2015
Q1 | $832K | Buy |
65,338
+13,300
| +26% | +$169K | ﹤0.01% | 2926 |
|
|
2014
Q4 | $736K | Sell |
52,038
-1,514
| -3% | -$21.4K | ﹤0.01% | 3014 |
|
|
2014
Q3 | $736K | Sell |
53,552
-13,467
| -20% | -$185K | ﹤0.01% | 2927 |
|
|
2014
Q2 | $1.03M | Sell |
67,019
-3,226
| -5% | -$49.6K | ﹤0.01% | 2686 |
|
|
2014
Q1 | $1.2M | Buy |
70,245
+1,477
| +2% | +$25.2K | ﹤0.01% | 2527 |
|
|
2013
Q4 | $891K | Buy |
68,768
+17,039
| +33% | +$221K | ﹤0.01% | 2755 |
|
|
2013
Q3 | $522K | Buy |
51,729
+16,155
| +45% | +$163K | ﹤0.01% | 3067 |
|
|
2013
Q2 | $266K | Buy |
+35,574
| New | +$266K | ﹤0.01% | 3333 |
|